Pham Tammy, Milanaik Ruth, Kaplan Alyson, Papaioannou Helen, Adesman Andrew
Division of Developmental and Behavioral Pediatrics, Steven and Alexandra Cohen Children's Medical Center of New York , Lake Success, New York.
J Child Adolesc Psychopharmacol. 2017 Oct;27(8):741-746. doi: 10.1089/cap.2016.0058. Epub 2017 Jul 7.
The primary objective of this study is to investigate household diversion of stimulant medication. Secondary objectives are to examine clinical/demographic predictors of diversion, types of formulations diverted, exposure to household diversion in the media, and storage of prescription stimulants within households.
Questionnaires were completed by 180 parents of youth who were currently taking stimulant medication for treatment of attention-deficit/hyperactivity disorder (ADHD). Parents were asked whether they or another adult in the home had ever taken their child's stimulant medication or given one child's stimulant medication to another child in the home. Additionally, data regarding demographics, parental ADHD (diagnosed or suspected), past suspicions of missing medication, and medication storage were also collected. Responses were compared using Pearson's chi-squared test with Yates' continuity correction.
Sixteen percent of parents reported diversion of stimulant medication to another household member, with the majority admitting to taking the medication themselves. Another 13% had been tempted to illicitly self-administer their child's medication. Parents with suspected or diagnosed ADHD showed greater risk of self-administration or temptation to do so, compared to parents without (33% vs. 17%, p = 0.01). The majority of parents (71%) stored prescription stimulants "in plain sight," or "out of sight but available to all."
Although previous research has focused on peer diversion among adolescents and young adults, clinicians must be vigilant for the possibility of diversion by parents of children treated with stimulant medication.
本研究的主要目的是调查刺激性药物在家庭中的转移情况。次要目的是检查转移的临床/人口统计学预测因素、转移的制剂类型、媒体中家庭转移的曝光情况以及家庭中处方兴奋剂的储存情况。
180名正在为患有注意力缺陷多动障碍(ADHD)的青少年服用刺激性药物的家长完成了问卷调查。家长们被问及他们或家中的另一位成年人是否曾服用过孩子的刺激性药物,或者是否将一个孩子的刺激性药物给了家中的另一个孩子。此外,还收集了有关人口统计学、父母ADHD(已诊断或疑似)、过去对药物缺失的怀疑以及药物储存的数据。使用带有耶茨连续性校正的皮尔逊卡方检验对回答进行比较。
16%的家长报告说刺激性药物被转移给了另一位家庭成员,大多数人承认是自己服用了药物。另有13%的家长曾有过非法自行服用孩子药物的想法。与没有ADHD的家长相比,疑似或已诊断患有ADHD的家长自行服药或有此想法的风险更高(33%对17%,p = 0.01)。大多数家长(71%)将处方兴奋剂“放在显眼处”或“放在看不见但所有人都能拿到的地方”。
尽管先前的研究集中在青少年和年轻人之间的同伴转移,但临床医生必须警惕接受刺激性药物治疗的儿童的家长进行转移的可能性。